DO34 analog |
| Katalog-Nr.GC31496 |
Das DO34-Analogon ist ein Triazol-DAGL(α)-Inhibitor, der aus dem Patent WO2017096315 A1, Verbindung 100, extrahiert wurde.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2098969-71-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100.
[1]. WO 2017096315 A1.
Review for DO34 analog
Average Rating: 5 (Based on Reviews and 26 reference(s) in Google Scholar.)
Review for DO34 analog
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *